610 Main Street, 3rd Floor
Cambridge, MA 02139
Pfizer Kendall Square is the R&D innovation engine that drives portfolio and business success for Pfizer Worldwide Research and Development. Our success is measured on our breakthroughs in science that make a tangible contribution to the patients who will benefit. We are Where Breakthroughs Begin. Opened in 2014, over 1,000 colleagues now call Kendall Square home where they focus on transforming scientific knowledge into medical breakthroughs. Our scientists work in state-of-the-art laboratory space driving a range of discovery and clinical programs in Metabolic Disease and Cardiovascular Risk, Neuroscience, Inflammation & Immunology and Rare Disease therapeutic areas. The site is also home to Pfizer’s large molecule discovery efforts, medicinal sciences, and early clinical development teams.
Strategically located in Kendall Square, we are well positioned to develop collaborations and partnerships on the forefront of innovation in this rich biomedical community. Pfizer Kendall Square is also the host to Pfizer’s R&D Incubator space that attracts top biotech companies and our Center for Therapeutic Innovation (CTI) group, which provides a bridge to an entrepreneurial network of collaborations with leading academic medical centers.
Pfizer KSQ is truly Where Breakthroughs Begin.